Replies to post #286004 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

Can't disagree with you here. I just think we will not see TLD anytime soon or LP would not have raised the funds...but I could be wrong.

But I am still hoping (albeit with less confidence now) none of this matter and all of us longs will be rewarded soon.

The loan did give the appearance that the need for dilutive financing was behind including me. However this run I think was predicated on the expectation of datalock this week and I don't think it was all pump and dump and I don't think it was all Sushifishman either by himself or his group. So a confluence of events drove up the price. We will see how much it retraces Monday if any. The dilution was minimal and offset by expired warrants so I see it as net neutral.

[Johnni]

“... this run I think was predicated on the expectation of datalock this week and I don't think it was all pump and dump ...”

But wasn’t pump and dump exactly what it was? For years now, the pattern: The company announces or hints at an anticipated milestone every few months. They seem to have a sense of exactly how many weeks or months our patience will keep us hooked on the line. A week or two before the expected milestone, the price rises with the excitement. The deadline passes, and the price crashes, often lower than before. Everyone reviews the wording the company used to telegraph the milestone, and we realize it was almost all in our own heads. They’ve used very careful language to cover their own buttocks, and in reality they promised nothing. And then there is an SEC filing indicating a financing deal occurred. We realize that during the run up not only were a high volume of investors buying, but also a high volume were selling — at a profit over the financing terms.

Right?

[Pablosrv]

Maybe you should put together a graph with each of these run ups followed by financing. You that like graphs so much. All that technical analysis worthless in the face of stock price manipulation and destruction of retail shareholders.